Switch-to-Semaglutide Study (STS-Study): a Retrospective Cohort Study

INTRODUCTION: Despite expert consensus guidelines, data is scarce on how to switch patients with type 2 diabetes when treatment with glucagon-like peptide 1 (GLP-1) receptor agonists is not effective and whether a switch to semaglutide brings any benefit on glucose and weight control for patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hepprich, Matthias, Zillig, Daniela, Florian-Reynoso, Manuel A., Donath, Marc Y., Rudofsky, Gottfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947039/
https://www.ncbi.nlm.nih.gov/pubmed/33615400
http://dx.doi.org/10.1007/s13300-021-01016-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947039/
https://www.ncbi.nlm.nih.gov/pubmed/33615400
http://dx.doi.org/10.1007/s13300-021-01016-y

Ejemplares similares